Stay updated on Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. This appears to be a minor version update without visible changes to content or user-facing features.
    Difference
    0.1%
    Check dated 2026-04-17T13:52:02.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added and Revision: v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-19T23:45:46.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. This change does not alter any study data, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2026-03-12T19:41:57.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 on the page.
    Difference
    0.1%
    Check dated 2026-02-12T01:46:39.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-04T23:44:25.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page now includes a glossary toggle, capitalization updates to metadata labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and a new revision tag v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T19:41:56.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page.